HPV DNA testing a ''rational approach'' to screening: study 26 Aug 2011 0 comments A major US trial adds weight to the argument that HPV DNA testing should be the primary screening tool for cervical cancer.
Oncologists voice caution over delayed oophorectomy 26 Aug 2011 0 comments It is too early to translate the tubal hypothesis of ovarian cancer into clinical practice by delaying oopherectomy, an Australian oncologist warns.
Pessimistic outlook for ovarian cancer screening 16 Dec 2010 0 comments Hopes that screening for ovarian cancer will reduce the mortality from the disease are likely to be over-stated, a new analysis has indicated.
Promising ovarian cancer drug 11 Nov 2010 0 comments A phase 3 trial of a new ovarian cancer drug has shown promising results, Associate Professor Gary Richardson from Monash University told the Clinical Oncological Society of Australia Annual
Hung jury on endometrial cancer surgery 11 Nov 2010 0 comments Despite there now being three prospective trials on the surgical management of endometrial cancer a Sydney Oncologist says there is still no convincing data to show a long-term benefit of laparoscopy
Cancer culprits 21 Oct 2010 0 comments Eight HPV types are responsible for more than 90% of all cervical cancer cases worldwide, research suggests.
Carboplatin-paclitaxel remains best standard of care 21 Oct 2010 0 comments Adding topotecan to carboplatin plus paclitaxel does not improve progression-free survival in patients with ovarian cancer and leads to greater toxicity, a study finds.
Early treatment of relapsed disease not necessarily better 8 Oct 2010 0 comments Early chemotherapy treatment for women with relapsed ovarian cancer does not extend survival or improve quality of life, research shows.
Doctors not missing ovarian cancer 23 Sep 2010 0 comments Late presentation rather than doctors failing to diagnose is to blame for the poor prognosis of most ovarian cancer patients, Australian research suggests.
Simple measures up cancer prevention 9 Sep 2010 0 comments The efficiency of current cancer prevention policies could be improved by some simple measures including raising the starting age of the cervical cancer screening program and extending the screening